A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/17 (2006.01) A61P 9/10 (2006.01) A61M 25/00 (2006.01)
Patent
CA 2419385
Use of the polypeptide Saratin for the manufacture of a medicament having the capability to significantly decrease platelet adhesion and platelet accumulation after vascular injuries or endarterectomy. The invention furthermore relates to a novel medical use of Saratin as an inhibitor of thrombosis and intimal hyperplasia, wherein said polypeptide may be used locally as a topical agent or as a coating on, or otherwise incorporated or associated with medical devices.
L'invention concerne l'utilisation du polypeptide Saratin dans la fabrication d'un médicament capable de réduire de manière significative l'adhésion et l'accumulation des plaquettes faisant suite à des lésions vasculaires ou à une endartériectomie. L'invention concerne également une nouvelle utilisation médicale du Saratin, en tant qu'un inhibiteur de thrombose et d'hyperplasie intime, ledit polypeptide pouvant être utilisé localement comme agent topique ou comme revêtement sur des dispositifs médicaux, ou incorporé ou associé d'une façon quelconque avec ceux-ci.
Barnes Christopher
Frech Matthias
Gleitz Johannes
Hofmann Uwe
Strittmatter Wolfgang
Fetherstonhaugh & Co.
Merck Patent Gesellschaft Mit Beschraenkter Haftung
LandOfFree
Saratin for inhibiting platelet adhesion to collagen does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Saratin for inhibiting platelet adhesion to collagen, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Saratin for inhibiting platelet adhesion to collagen will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1804842